Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCK | P35557 | 13/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2642383 | 0.83 | GCK (0.48) | GCK | |
| SCHEMBL2213982 | 0.82 | GCK (0.63) | GCKMEN1NPC1MGAMALDH1A1 | |
| SCHEMBL2213370 | 0.80 | GCK (0.73) | GCKMEN1NPC1MGAMALDH1A1 | |
| SCHEMBL2643024 | 0.79 | GCK (1.00) | GCKSMN1; SMN2 | |
| SCHEMBL2213443 | 0.79 | GCK (0.71) | GCKMEN1NPC1MGAMALDH1A1 | |
| SCHEMBL2213619 | 0.76 | GCK (0.72) | GCK | |
| SCHEMBL2210526 | 0.73 | GCK (0.67) | GCK | |
| SCHEMBL2212679 | 0.71 | GCK (0.75) | GCK | |
| SCHEMBL2250207 | 0.71 | GCK (0.59) | GCKNPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL2212557 | 0.71 | GCK (0.73) | GCKNPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1598349-B1 | NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES | MSD KK (JP) | 2011-07-27 | — | — | EP | claimed |